Sandor Victor 4
4 · Prelude Therapeutics Inc · Filed Nov 7, 2025
Insider Transaction Report
Form 4
Sandor Victor
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2025-11-05+121,285→ 121,285 totalExercise: $1.39Exp: 2035-11-04→ Common Stock (121,285 underlying)
Footnotes (1)
- [F1]The option award vests over a one year period equally one-twelfth per month, subject to Reporting Person's continued service to the Company on each vesting date.